300 related articles for article (PubMed ID: 18646606)
1. [Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease].
Kawa K
Rinsho Ketsueki; 2008 Jun; 49(6):390-6. PubMed ID: 18646606
[No Abstract] [Full Text] [Related]
2. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
3. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
[TBL] [Abstract][Full Text] [Related]
4. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K
Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
6. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.
Okamura T; Hatsukawa Y; Arai H; Inoue M; Kawa K
Lancet; 2000 Jul; 356(9225):223-4. PubMed ID: 10963205
[TBL] [Abstract][Full Text] [Related]
7. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
8. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
[TBL] [Abstract][Full Text] [Related]
9. [EBV-positive T/NK lymphoproliferative disease in childhood].
Kimura H
Nihon Rinsho; 2012 Apr; 70 Suppl 2():692-6. PubMed ID: 23134030
[No Abstract] [Full Text] [Related]
10. Impact of melphalan dose during reduced-intensity conditioning on engraftment of cord blood transplantation for chronic Epstein-Barr virus-associated T or NK cell lymphoproliferative diseases.
Mayumi A; Sawada A; Sato M; Shimizu M; Ioi A; Higuchi K; Yasui M; Kawa K; Inoue M
Pediatr Blood Cancer; 2020 Sep; 67(9):e28536. PubMed ID: 32564520
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Kimura H
Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated lymphoproliferative disorders.
Rezk SA; Weiss LM
Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
Yachie A; Kanegane H; Kasahara Y
Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment for EBV-associated lymphoproliferative disease].
Kawa K
Nihon Rinsho; 2006 Mar; 64 Suppl 3():682-6. PubMed ID: 16615559
[No Abstract] [Full Text] [Related]
16. Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases.
Sawada A; Inoue M; Koyama-Sato M; Kondo O; Yamada K; Shimizu M; Isaka K; Kimoto T; Kikuchi H; Tokimasa S; Yasui M; Kawa K
Biol Blood Marrow Transplant; 2014 Feb; 20(2):214-21. PubMed ID: 24188918
[TBL] [Abstract][Full Text] [Related]
17. Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated.
Gottschalk S
Bone Marrow Transplant; 2011 Jan; 46(1):18-9. PubMed ID: 20956953
[No Abstract] [Full Text] [Related]
18. Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
Cai Q; Chen K; Young KH
Exp Mol Med; 2015 Jan; 47(1):e133. PubMed ID: 25613730
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.
Milpied N; Coste-Burel M; Accard F; Moreau A; Moreau P; Garand R; Harousseau JL
Bone Marrow Transplant; 1999 Mar; 23(6):629-30. PubMed ID: 10217196
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for adults with EBV-positive T- or NK-cell lymphoproliferative disorders: efficacy and predictive markers.
Arai A; Sakashita C; Hirose C; Imadome KI; Yamamoto M; Jinta M; Fujiwara S; Tomita M; Shimizu N; Morio T; Miura O
Bone Marrow Transplant; 2016 Jun; 51(6):879-82. PubMed ID: 26901705
[No Abstract] [Full Text] [Related]
[Next] [New Search]